Evidence map›Paper›PMID 38715917›Full record

ArticleJournal of medical cases2024

Recurrent Takotsubo Cardiomyopathy due to Pheochromocytoma Managed With Venoarterial Extracorporeal Membrane Oxygenation.

Georgia Karmioti, Stefanos Sakellaropoulos, Inan Sarikaya, Antonia Kastoris, Christina Hadjilouka, Christos Efseviou, Michael Myrianthefs, Andreas Mitsis

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Georgia KarmiotiCardiology Department, Nicosia General Hospital, Nicosia, Cyprus.
Stefanos SakellaropoulosDepartment of Internal Medicine, Cardiology Clinic, Kantonsspital Baden, Baden, Switzerland.
Inan SarikayaPraxis Gruppe Wurenlingen, Internal Medicine, Wurenlingen, Switzerland.
Antonia KastorisIntensive Care Unit, Nicosia General Hospital, Nicosia, Cyprus.
Christina HadjiloukaIntensive Care Unit, Nicosia General Hospital, Nicosia, Cyprus.
Christos EfseviouIntensive Care Unit, Nicosia General Hospital, Nicosia, Cyprus.
Michael MyrianthefsCardiology Department, Nicosia General Hospital, Nicosia, Cyprus.
Andreas MitsisCardiology Department, Nicosia General Hospital, Nicosia, Cyprus.ORCID https://orcid.org/0000-0002-0286-7762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheochromocytoma-induced Takotsubo cardiomyopathy is a rare but life-threatening condition, caused by excessive plasma catecholamine levels, resulting in acute myocardial dysfunction. Clinical presentation includes a rapid development of heart failure due to regional wall motion abnormalities (most commonly affecting all mid to apical left ventricle (LV) wall segments) causing the "octopus-trap-like" LV shape. A 45-year-old female patient presented with acute cardiogenic shock of non-ischemic etiology. Her past medical history included a similar episode, which was followed by full recovery, but at this admission she required hemodynamic support with venoarterial extracorporeal membrane oxygenation. The systolic function was restored, and further investigation revealed high 24-h urine metanephrine levels and a mass of the left adrenal gland, leading to the diagnosis of pheochromocytoma. After treatment with firstly alpha-blockers and then beta-blockers, the pheochromocytoma was surgically removed.

Indexed as

Cardiogenic shockHeart failurePheochromocytomaTakotsubo cardiomyopathyVenoarterial extracorporeal membrane oxygenation

Identifiers

PMID38715917
PMCPMC11073464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.